検索結果 - Ekram Gad

  • 検索結果 1 - 11 結果 / 11
結果の絞り込み
  1. 1
    TLR2 Agonist PSK Activates Human NK Cells and Enhances the Antitumor Effect of HER2-Targeted Monoclonal Antibody Therapy

    TLR2 Agonist PSK Activates Human NK Cells and Enhances the Antitumor Effect of HER2-Targeted Monoclonal Antibody Therapy 著者: Hailing Lu, Yi Yang, Ekram Gad, Carol Inatsuka, Cynthia A. Wenner, Mary L. Disis, Leanna J. Standish

    出版事項 2011
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  2. 2
    Dendritic Cell–Activating Vaccine Adjuvants Differ in the Ability to Elicit Antitumor Immunity Due to an Adjuvant-Specific Induction of Immunosuppressive Cells

    Dendritic Cell–Activating Vaccine Adjuvants Differ in the Ability to Elicit Antitumor Immunity Due to an Adjuvant-Specific Induction of Immunosuppressive Cells 著者: Yushe Dang, Wolfgang Wagner, Ekram Gad, Lauren Rastetter, Carmen M. Berger, Gregory E. Holt, Mary L. Disis

    出版事項 2012
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  3. 3
    Three-Dimensional Scaffolds to Evaluate Tumor Associated Fibroblast-Mediated Suppression of Breast Tumor Specific T Cells

    Three-Dimensional Scaffolds to Evaluate Tumor Associated Fibroblast-Mediated Suppression of Breast Tumor Specific T Cells 著者: Vy Phan-Lai, Stephen J. Florczyk, Forrest M. Kievit, Kui Wang, Ekram Gad, Mary L. Disis, Miqin Zhang

    出版事項 2013
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  4. 4
    IL-2 Immunotoxin Therapy Modulates Tumor-Associated Regulatory T Cells and Leads to Lasting Immune-Mediated Rejection of Breast Cancers in <i>neu</i>-Transgenic Mice

    IL-2 Immunotoxin Therapy Modulates Tumor-Associated Regulatory T Cells and Leads to Lasting Immune-Mediated Rejection of Breast Cancers in <i>neu</i>-Transgenic Mice 著者: Keith L. Knutson, Yushe Dang, Hailing Lu, Jason Lukas, Bond Almand, Ekram Gad, Ehizoje Azeke, Mary L. Disis

    出版事項 2006
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  5. 5
    Immunoediting of Cancers May Lead to Epithelial to Mesenchymal Transition

    Immunoediting of Cancers May Lead to Epithelial to Mesenchymal Transition 著者: Keith L. Knutson, Hailing Lu, Brad Stone, Jennifer M. Reiman, Marshall D. Behrens, Christine Prosperi, Ekram Gad, Arianna Smorlesi, Mary L. Disis

    出版事項 2006
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  6. 6
    The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity

    The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity 著者: Marshall D. Behrens, Wolfgang Wagner, Christopher J. Krco, Courtney L. Erskine, Kimberly R. Kalli, James Krempski, Ekram Gad, Mary L. Disis, Keith L. Knutson

    出版事項 2007
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  7. 7
    Insulin-like Growth Factor–Binding Protein-2 Is a Target for the Immunomodulation of Breast Cancer

    Insulin-like Growth Factor–Binding Protein-2 Is a Target for the Immunomodulation of Breast Cancer 著者: Kyong Hwa Park, Ekram Gad, Vivian Goodell, Yushe Dang, Thayer Wild, Doreen M. Higgins, Patty Fintak, Jennifer S. Childs, Corazon dela Rosa, Mary L. Disis

    出版事項 2008
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  8. 8
    Polysaccharide Krestin Is a Novel TLR2 Agonist that Mediates Inhibition of Tumor Growth via Stimulation of CD8 T Cells and NK Cells

    Polysaccharide Krestin Is a Novel TLR2 Agonist that Mediates Inhibition of Tumor Growth via Stimulation of CD8 T Cells and NK Cells 著者: Hailing Lu, Yi Yang, Ekram Gad, Cynthia A. Wenner, Amy Chang, Emily R. Larson, Yushe Dang, Mark R. Martzen, Leanna J. Standish, Mary L. Disis

    出版事項 2010
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  9. 9
    Treatment Failure of a TLR-7 Agonist Occurs Due to Self-Regulation of Acute Inflammation and Can Be Overcome by IL-10 Blockade

    Treatment Failure of a TLR-7 Agonist Occurs Due to Self-Regulation of Acute Inflammation and Can Be Overcome by IL-10 Blockade 著者: Hailing Lu, Wolfgang Wagner, Ekram Gad, Yi Yang, Hangjun Duan, Lynn M. Amon, Nathaniel Van Denend, Emily R. Larson, Amy Chang, Helena Tufvesson, Mary L. Disis

    出版事項 2010
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  10. 10
    A Multiantigen Vaccine Targeting Neu, IGFBP-2, and IGF-IR Prevents Tumor Progression in Mice with Preinvasive Breast Disease

    A Multiantigen Vaccine Targeting Neu, IGFBP-2, and IGF-IR Prevents Tumor Progression in Mice with Preinvasive Breast Disease 著者: Mary L. Disis, Ekram Gad, Daniel R. Herendeen, Vy P. Lai, Kyong Hwa Park, Denise L. Cecil, Megan M. O’Meara, Piper M. Treuting, Ronald A. Lubet

    出版事項 2013
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  11. 11
    Systemically administered low-affinity HER2 CAR T cells mediate antitumor efficacy without toxicity

    Systemically administered low-affinity HER2 CAR T cells mediate antitumor efficacy without toxicity 著者: Tamer B. Shabaneh, Andrew R. Stevens, Sylvia M. Stull, Kristen R Shimp, Brandon Seaton, Ekram Gad, Carla A. Jaeger-Ruckstuhl, Sylvain Simon, Amanda Koehne, Jason P. Price, James M. Olson, Benjamin G. Hoffstrom, David Jellyman, Stanley R. Riddell

    出版事項 2024
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:

検索ツール: